STAAR Surgical Company (STAA)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current STAA market cap is 841.94M. The company's latest EPS is USD -0.4080 and P/E is -42.01.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 77.36M | 99.01M | 88.59M | 48.95M | 42.59M |
| Operating Income | -2.28M | 11.9M | 5.68M | -26.22M | -57.4M |
| Net Income | -3.34M | 7.38M | 9.98M | -34.23M | -54.21M |
| Year End December 26 2024 | 2021 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 163.46M | 230.47M | 284.39M | 322.42M | 313.9M |
| Operating Income | 6.77M | 33.34M | 43.8M | 28.1M | -10.92M |
| Net Income | 5.91M | 24.5M | 38.76M | 21.35M | -20.21M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 492.54M | 512.75M | 537.59M | 509.52M | 457.36M |
| Total Liabilities | 99.75M | 103.64M | 109.47M | 112.19M | 107.39M |
| Total Equity | 392.79M | 409.1M | 428.12M | 397.34M | 349.97M |
| Year End December 26 2024 | 2021 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 257.42M | 345.78M | 414.9M | 488.69M | 509.52M |
| Total Liabilities | 60.19M | 87.22M | 82.71M | 102.74M | 112.19M |
| Total Equity | 197.22M | 258.56M | 332.19M | 385.95M | 397.34M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 21.68M | 11.27M | 15.08M | 15.73M | -5.73M |
| Investing | 16.19M | -4.48M | -39.72M | -59.22M | 35.35M |
| Financing | 4.06M | 4.22M | 5.83M | 5.72M | -948k |
| Year End December 26 2024 | 2021 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 20.95M | 43.96M | 35.72M | 14.59M | 15.73M |
| Investing | -8.4M | -13.65M | -156.38M | 74.35M | -59.22M |
| Financing | 19.57M | 17.79M | 8.3M | 7.42M | 5.72M |
| Market Cap | 841.94M |
| Price to Earnings Ratio | -42.01 |
| Price to Sales Ratio | 2.7 |
| Price to Cash Ratio | 5.89 |
| Price to Book Ratio | 2.14 |
| Dividend Yield | - |
| Shares Outstanding | 49.53M |
| Average Volume (1 week) | 608.36k |
| Average Volume (1 Month) | 778.7k |
| 52 Week Change | -60.40% |
| 52 Week High | 49.86 |
| 52 Week Low | 13.50 |
| Spread (Intraday) | 0.26 (1.52%) |
| Company Name | STAAR Surgical Company |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://staar.com |
| Industry | ophthalmic goods (3851) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
